Sharps Technology Inc. announced Thursday that it has authorized a $100 million stock repurchase program, pointing to its commitment to enhancing shareholder value. A $100M Buyback? Sharps Technology Thinks It’s Worth It The medical device company, listed on Nasdaq under STSS, said it will repurchase up to $100 million worth of its common stock through […]
